achillestx.com (ACHL) Cash Funds per Single Share

Symbol and logo of brand Achilles Therapeutics plc (ACHL)

Achilles Therapeutics (ACHL) is developing unique methods for combating solid tumors through partnerships with oncology centers. An analysis of cash per share shows that the value of this metric is 2.10. Liquidity is supported by the sector's independence from macroeconomics, although product scaling relies on external contract manufacturers and strict international compliance.

ACHL achillestx.com: Cash per Single Share in the range 07/04/2022 - 03/29/2025

Comprehensive metric breakdowns and analytics for achillestx.com (ACHL)

- market price and analyst price targets:
Summary company analysis:ACHL (Achilles Therapeutics PLC)
Finished products of Achilles Therapeutics

This indicator determines the intrinsic value of an asset through the lens of liquidity. By analyzing the cash per share, an investor assesses the company's actual cash cushion. The metric is calculated by dividing the total amount of cash and cash equivalents by the number of shares outstanding. This metric confirms the financial stability of Achilles Therapeutics (ACHL). Maintaining proprietary sterile facilities in the UK requires constant capital to ensure operational stability.